MedPath

A study to compare the clinical efficacy & safety of equal doses of Hyperbaric ropivacaine vs Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery.

Not yet recruiting
Conditions
Tear of meniscus, current injury, (2) ICD-10 Condition: S832||Tear of meniscus, current injury,
Registration Number
CTRI/2023/09/057327
Lead Sponsor
FORTIS HOSPITAL
Brief Summary

Our study is a randomised prospective double blind study that will be done to compare the efficacy and safety of the two study drugs namely hyperbaric 0.75% ropivacaine and  hyperbaric 0.5% bupivacaine. The study will be done in patients undergoing elective knee arthroscopic surgery being conducted at Fortis Hospital Mohali in the department of anaesthesia and critical care.

Sample size of eighty will be taken and block randomisation done with Computerized Randomization Technique. Both the drugs would be distributed among the participants. The effect of the study drugs will be assessed using parameters like the onset of sensory and motor blocks ,time for regression from T10 level, complete duration of block and side-effect profiles etc. At the end, result of both the drugs will be compared and statistically analysed .Any complications will also be recorded.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Willing to participate, ASA grade 1 and 2, Age- 16-65 years, Either gender scheduled for elective knee arthroscopic surgery under spinal anaesthesia, Pt with BMI less then 35, Patients who have given valid informed written consent.

Exclusion Criteria
  • Patients of American society of Anaesthesiologists 3 and 4, Patient refusal , Infection at the site of administration, Coagulopathy , Spinal deformity, Allergic to local anesthetic drugs , Lack of informed written consent , Duration of surgery greater than 120 mins, Patients having allergy to study drug, Patients with psychiatric disorder or history of drug abuse.
  • Patient unable to comprehend, Morbidly obese patients (BMI greater than 35kg per m2), Pregnant patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the clinical efficacy & safety of equal doses 3ml of 0.75 % Hyperbaric ropivacaine with 3ml of 0.5% Hyperbaric bupivacaine for sub arachnoid block in knee arthroscopic surgery for a duration of 16 to 18 months1.The onset of Sensory block till T 10 | 2.The onset of Motor block. | 3.Time for two segment regression of sensory block | 4.The complete duration of sensory & motor block | 5.Intraoperative Haemodynamics. | 6.Intraoperative complications. | 7.Time to first rescue analgesic. | 8.Time to micturition. | for a duration of 16 to 18 months
Secondary Outcome Measures
NameTimeMethod
To study & compare the side effect profile of the two drugs,To study the intraoperative and post operative complications.

Trial Locations

Locations (1)

Fortis hospital mohali

🇮🇳

Chandigarh, CHANDIGARH, India

Fortis hospital mohali
🇮🇳Chandigarh, CHANDIGARH, India
Dr Dinesh Kataria
Principal investigator
9872217274
drkat22in@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.